Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 288

1.

Cardiac Troponin I and T Are Associated with Left Ventricular Function and Structure: Data from the Akershus Cardiac Examination 1950 Study.

Lyngbakken MN, Aagaard EN, Kvisvik B, Berge T, Pervez MO, Brynildsen J, Tveit A, Steine K, Røsjø H, Omland T.

Clin Chem. 2020 Apr 1;66(4):567-578. doi: 10.1093/clinchem/hvaa023.

PMID:
32227098
2.

Endurance exercise training volume is not associated with progression of coronary artery calcification.

Kleiven Ø, Bjørkavoll-Bergseth MF, Omland T, Aakre KM, Frøysa V, Erevik CB, Greve OJ, Melberg TH, Auestad B, Skadberg Ø, Edvardsen T, Ørn S.

Scand J Med Sci Sports. 2020 Feb 25. doi: 10.1111/sms.13643. [Epub ahead of print]

PMID:
32100340
3.

Reply: The complementary role of cardiac troponin I and cardiac troponin T.

Tveit SH, Myhre PL, Røsjø H, Omland T.

Clin Biochem. 2020 Feb 20. pii: S0009-9120(20)30115-6. doi: 10.1016/j.clinbiochem.2020.02.011. [Epub ahead of print] No abstract available.

PMID:
32088145
4.

Targeting NAD+ in translational research to relieve diseases and conditions of metabolic stress and ageing.

Gilmour BC, Gudmundsrud R, Frank J, Hov A, Lautrup S, Aman Y, Røsjø H, Brenner C, Ziegler M, Tysnes OB, Tzoulis C, Omland T, Søraas A, Holmøy T, Bergersen LH, Storm-Mathisen J, Nilsen H, Fang EF.

Mech Ageing Dev. 2020 Mar;186:111208. doi: 10.1016/j.mad.2020.111208. Epub 2020 Jan 15. Review.

PMID:
31953124
5.

Superiority of high sensitivity cardiac troponin T vs. I for long-term prognostic value in patients with chest pain; data from the Akershus cardiac Examination (ACE) 3 study.

Tveit SH, Myhre PL, Hoff NJS, Le TM, Seljeflot I, Røysland R, Høiseth AD, Røsjø H, Omland T.

Clin Biochem. 2019 Dec 31. pii: S0009-9120(19)31030-6. doi: 10.1016/j.clinbiochem.2019.12.016. [Epub ahead of print]

6.

Dipeptidyl peptidase 3, a biomarker in cardiogenic shock and hopefully much more.

Magliocca A, Omland T, Latini R.

Eur J Heart Fail. 2020 Feb;22(2):300-302. doi: 10.1002/ejhf.1649. Epub 2019 Dec 15. No abstract available.

PMID:
31840335
7.

Current Smoking Is Associated With Lower Concentrations of High-Sensitivity Cardiac Troponin T in Patients With Stable Coronary Artery Disease: The PEACE Trial.

Skranes JB, Claggett BL, Myhre PL, Lyngbakken MN, Solomon SD, Sabatine MS, Pfeffer MA, Omland T.

Circulation. 2019 Dec 10;140(24):2044-2046. doi: 10.1161/CIRCULATIONAHA.119.041991. Epub 2019 Dec 9. No abstract available.

PMID:
31815543
8.

Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium.

Brunner FJ, Waldeyer C, Ojeda F, Salomaa V, Kee F, Sans S, Thorand B, Giampaoli S, Brambilla P, Tunstall-Pedoe H, Moitry M, Iacoviello L, Veronesi G, Grassi G, Mathiesen EB, Söderberg S, Linneberg A, Brenner H, Amouyel P, Ferrières J, Tamosiunas A, Nikitin YP, Drygas W, Melander O, Jöckel KH, Leistner DM, Shaw JE, Panagiotakos DB, Simons LA, Kavousi M, Vasan RS, Dullaart RPF, Wannamethee SG, Risérus U, Shea S, de Lemos JA, Omland T, Kuulasmaa K, Landmesser U, Blankenberg S; Multinational Cardiovascular Risk Consortium.

Lancet. 2019 Dec 14;394(10215):2173-2183. doi: 10.1016/S0140-6736(19)32519-X. Epub 2019 Dec 3. Erratum in: Lancet. 2019 Dec 6;:. Erratum in: Lancet. 2020 Jan 4;395(10217):32.

9.

Targeting the endothelin system: a step towards a precision medicine approach in heart failure with preserved ejection fraction?

Omland T.

Eur Heart J. 2019 Dec 1;40(45):3718-3720. doi: 10.1093/eurheartj/ehz765. No abstract available.

PMID:
31682255
10.

Racial Differences in Cardiovascular Biomarkers in the General Population.

Hackler E 3rd, Lew J, Gore MO, Ayers CR, Atzler D, Khera A, Rohatgi A, Lewis A, Neeland I, Omland T, de Lemos JA.

J Am Heart Assoc. 2019 Sep 17;8(18):e012729. doi: 10.1161/JAHA.119.012729. Epub 2019 Sep 13.

11.

Left ventricular mechanical dispersion in a general population: Data from the Akershus Cardiac Examination 1950 study.

Aagaard EN, Kvisvik B, Pervez MO, Lyngbakken MN, Berge T, Enger S, Orstad EB, Smith P, Omland T, Tveit A, Røsjø H, Steine K.

Eur Heart J Cardiovasc Imaging. 2020 Feb 1;21(2):183-190. doi: 10.1093/ehjci/jez210.

PMID:
31504360
12.

Association Between Circulating Troponin Concentrations, Left Ventricular Systolic and Diastolic Functions, and Incident Heart Failure in Older Adults.

Myhre PL, Claggett B, Ballantyne CM, Selvin E, Røsjø H, Omland T, Solomon SD, Skali H, Shah AM.

JAMA Cardiol. 2019 Sep 4. doi: 10.1001/jamacardio.2019.3113. [Epub ahead of print]

PMID:
31483438
13.

Cardiac Troponin Increase After Endurance Exercise.

Omland T, Aakre KM.

Circulation. 2019 Sep 9;140(10):815-818. doi: 10.1161/CIRCULATIONAHA.119.042131. Epub 2019 Sep 3. No abstract available.

PMID:
31479313
14.

Circulating microRNAs as predictive biomarkers of myocardial infarction: Evidence from the HUNT study.

Velle-Forbord T, Eidlaug M, Debik J, Sæther JC, Follestad T, Nauman J, Gigante B, Røsjø H, Omland T, Langaas M, Bye A.

Atherosclerosis. 2019 Oct;289:1-7. doi: 10.1016/j.atherosclerosis.2019.07.024. Epub 2019 Jul 26.

PMID:
31437610
15.

Educational Recommendations on Selected Analytical and Clinical Aspects of Natriuretic Peptides with a Focus on Heart Failure: A Report from the IFCC Committee on Clinical Applications of Cardiac Bio-Markers.

Kavsak PA, Lam CSP, Saenger AK, Jaffe AS, Collinson P, Pulkki K, Omland T, Lefèvre G, Body R, Ordonez-Llanos J, Apple FS.

Clin Chem. 2019 Oct;65(10):1221-1227. doi: 10.1373/clinchem.2019.306621. Epub 2019 Aug 6.

PMID:
31387884
16.

Role of BNP vs NT-proBNP Testing in the Age of New Drug Therapies: Sacubitril-Valsartan.

Apple FS, Daniels LB, Januzzi J, Omland T, Ordonez-Llanos J, Jaffe A.

Clin Chem. 2019 Sep;65(9):1076-1083. doi: 10.1373/clinchem.2018.289371. Epub 2019 Jul 18. No abstract available.

PMID:
31320381
17.

Circulating secretoneurin concentrations in patients with moderate to severe aortic stenosis.

Brynildsen J, Myhre PL, Lyngbakken MN, Klaeboe LG, Stridsberg M, Christensen G, Edvardsen T, Omland T, Røsjø H.

Clin Biochem. 2019 Sep;71:17-23. doi: 10.1016/j.clinbiochem.2019.06.008. Epub 2019 Jun 19.

PMID:
31228433
18.

Aiming toWards Evidence baSed inTerpretation of Cardiac biOmarkers in patients pResenting with chest pain-the WESTCOR study: study design.

Tjora HL, Steiro OT, Langørgen J, Bjørneklett R, Nygård OK, Renstrøm R, Skadberg Ø, Bonarjee VVS, Lindahl B, Collinson P, Omland T, Vikenes K, Aakre KM.

Scand Cardiovasc J. 2019 Oct;53(5):280-285. doi: 10.1080/14017431.2019.1634280. Epub 2019 Jul 1.

PMID:
31216908
19.

Occult obstructive coronary artery disease is associated with prolonged cardiac troponin elevation following strenuous exercise.

Kleiven Ø, Omland T, Skadberg Ø, Melberg TH, Bjørkavoll-Bergseth MF, Auestad B, Bergseth R, Greve OJ, Aakre KM, Ørn S.

Eur J Prev Cardiol. 2019 Jun 1:2047487319852808. doi: 10.1177/2047487319852808. [Epub ahead of print]

PMID:
31154829
20.

Plasma marine n-3 polyunsaturated fatty acids and cardiovascular risk factors: data from the ACE 1950 study.

Chandra A, Røsjø H, Eide IA, Vigen T, Ihle-Hansen H, Orstad EB, Rønning OM, Lyngbakken MN, Berge T, Schmidt EB, Omland T, Tveit A, Svensson M.

Eur J Nutr. 2019 May 23. doi: 10.1007/s00394-019-02007-3. [Epub ahead of print]

PMID:
31123865
21.

Temporal Changes in Cardiac Troponin I Are Associated with Risk of Cardiovascular Events in the General Population: The Nord-Trøndelag Health Study.

Lyngbakken MN, Røsjø H, Holmen OL, Dalen H, Hveem K, Omland T.

Clin Chem. 2019 Jul;65(7):871-881. doi: 10.1373/clinchem.2018.301069. Epub 2019 Apr 17.

PMID:
30996050
22.

The rise and fall of the 99th percentile decision limit for cardiac troponins?

Aakre KM, Omland T.

Int J Cardiol. 2019 Aug 1;288:25-26. doi: 10.1016/j.ijcard.2019.02.071. Epub 2019 Mar 14. No abstract available.

PMID:
30955878
23.

Secretoneurin Is an Endogenous Calcium/Calmodulin-Dependent Protein Kinase II Inhibitor That Attenuates Ca2+-Dependent Arrhythmia.

Ottesen AH, Carlson CR, Eken OS, Sadredini M, Myhre PL, Shen X, Dalhus B, Laver DR, Lunde PK, Kurola J, Lunde M, Hoff JE, Godang K, Sjaastad I, Pettilä V, Stridsberg M, Lehnart SE, Edwards AG, Lunde IG, Omland T, Stokke MK, Christensen G, Røsjø H, Louch WE.

Circ Arrhythm Electrophysiol. 2019 Apr;12(4):e007045. doi: 10.1161/CIRCEP.118.007045.

PMID:
30943765
24.

Cardiac Troponin to Guide the Use of Noninvasive Testing in Patients Ruled Out for Myocardial Infarction.

Mills NL, Omland T.

Circulation. 2019 Apr 2;139(14):1655-1657. doi: 10.1161/CIRCULATIONAHA.118.038162. No abstract available. Erratum in: Circulation. 2019 Jul 16;140(3):e162.

PMID:
30933617
25.

Race duration and blood pressure are major predictors of exercise-induced cardiac troponin elevation.

Kleiven Ø, Omland T, Skadberg Ø, Melberg TH, Bjørkavoll-Bergseth MF, Auestad B, Bergseth R, Greve OJ, Aakre KM, Ørn S.

Int J Cardiol. 2019 May 15;283:1-8. doi: 10.1016/j.ijcard.2019.02.044. Epub 2019 Feb 23.

PMID:
30842026
26.

Physical activity, exercise and cardiac troponins: Clinical implications.

Aakre KM, Omland T.

Prog Cardiovasc Dis. 2019 Mar - Apr;62(2):108-115. doi: 10.1016/j.pcad.2019.02.005. Epub 2019 Feb 22. Review.

PMID:
30797799
27.

High-sensitivity troponin I for cardiovascular risk stratification in the general asymptomatic population: Perspectives from Asia-Pacific.

Lam CSP, Castillo R, Ho DT, Kasliwal RR, Khurana R, Naik S, Omland T, Parsonage WA, Phrommintikul A, Tobing D, Yiu KKH.

Int J Cardiol. 2019 May 1;282:93-98. doi: 10.1016/j.ijcard.2019.01.107. Epub 2019 Feb 1. Review.

PMID:
30745254
28.

Circulating Secretoneurin Concentrations After Cardiac Surgery: Data From the FINNish Acute Kidney Injury Heart Study.

Brynildsen J, Petäjä L, Myhre PL, Lyngbakken MN, Nygård S, Stridsberg M, Christensen G, Ottesen AH, Pettilä V, Omland T, Røsjø H.

Crit Care Med. 2019 May;47(5):e412-e419. doi: 10.1097/CCM.0000000000003670.

PMID:
30730440
29.

Can Circulating B-Type Natriuretic Peptide Concentrations Guide Treatment of Obstructive Left Main Coronary Artery Disease?

Omland T.

Circulation. 2018 Jul 31;138(5):479-482. doi: 10.1161/CIRCULATIONAHA.118.035272. No abstract available.

PMID:
30571535
30.

Novel biomarkers of cardiovascular disease: Applications in clinical practice.

Lyngbakken MN, Myhre PL, Røsjø H, Omland T.

Crit Rev Clin Lab Sci. 2019 Jan;56(1):33-60. doi: 10.1080/10408363.2018.1525335. Epub 2018 Nov 20. Review.

PMID:
30457415
31.

Cardiac troponin and natriuretic peptide analytical interferences from hemolysis and biotin: educational aids from the IFCC Committee on Cardiac Biomarkers (IFCC C-CB).

Saenger AK, Jaffe AS, Body R, Collinson PO, Kavsak PA, Lam CSP, Lefèvre G, Omland T, Ordóñez-Llanos J, Pulkki K, Apple FS.

Clin Chem Lab Med. 2019 Apr 24;57(5):633-640. doi: 10.1515/cclm-2018-0905.

32.

The authors reply.

Røsjø H, Caironi P, Meessen J, Latini R, Omland T; ALBIOS Biomarkers Study Investigators.

Crit Care Med. 2018 Sep;46(9):e959-e961. doi: 10.1097/CCM.0000000000003248. No abstract available.

PMID:
30113381
33.

Prevalence of atrial fibrillation and cardiovascular risk factors in a 63-65 years old general population cohort: the Akershus Cardiac Examination (ACE) 1950 Study.

Berge T, Lyngbakken MN, Ihle-Hansen H, Brynildsen J, Pervez MO, Aagaard EN, Vigen T, Kvisvik B, Christophersen IE, Steine K, Omland T, Smith P, Røsjø H, Tveit A.

BMJ Open. 2018 Aug 1;8(7):e021704. doi: 10.1136/bmjopen-2018-021704.

34.

Diagnostic and prognostic properties of procalcitonin in patients with acute dyspnea: Data from the ACE 2 Study.

Berge K, Lyngbakken MN, Einvik G, Winther JA, Brynildsen J, Røysland R, Strand H, Christensen G, Høiseth AD, Omland T, Røsjø H.

Clin Biochem. 2018 Sep;59:62-68. doi: 10.1016/j.clinbiochem.2018.07.006. Epub 2018 Jul 17.

PMID:
30028971
35.

Cardiac Troponin T Concentrations, Reversible Myocardial Ischemia, and Indices of Left Ventricular Remodeling in Patients with Suspected Stable Angina Pectoris: a DOPPLER-CIP Substudy.

Myhre PL, Omland T, Sarvari SI, Ukkonen H, Rademakers F, Engvall JE, Hagve TA, Nagel E, Sicari R, Zamorano JL, Monaghan M, D'hooge J, Edvardsen T, Røsjø H; DOPPLER-CIP Study Group.

Clin Chem. 2018 Sep;64(9):1370-1379. doi: 10.1373/clinchem.2018.288894. Epub 2018 Jun 29.

PMID:
29959147
36.

Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study.

Pervez MO, Winther JA, Brynildsen J, Strand H, Christensen G, Høiseth AD, Myhre PL, Røysland R, Lyngbakken MN, Omland T, Røsjø H.

Biomarkers. 2018 Nov;23(7):654-663. doi: 10.1080/1354750X.2018.1474258. Epub 2018 Sep 12.

PMID:
29733687
37.

The association between circulating adiponectin levels, lung function and adiposity in subjects from the general population; data from the Akershus Sleep Apnea Project.

Caspersen NF, Røsjø H, Flyvbjerg A, Bjerre M, Randby A, Hrubos-Strøm H, Omland T, Einvik G.

BMC Pulm Med. 2018 Apr 2;18(1):54. doi: 10.1186/s12890-018-0618-4.

38.

Relative Prognostic Value of Cardiac Troponin I and C-Reactive Protein in the General Population (from the Nord-Trøndelag Health [HUNT] Study).

Sigurdardottir FD, Lyngbakken MN, Holmen OL, Dalen H, Hveem K, Røsjø H, Omland T.

Am J Cardiol. 2018 Apr 15;121(8):949-955. doi: 10.1016/j.amjcard.2018.01.004. Epub 2018 Feb 2.

PMID:
29496193
39.

Prognostic Value of Secretoneurin in Patients With Severe Sepsis and Septic Shock: Data From the Albumin Italian Outcome Sepsis Study.

Røsjø H, Masson S, Caironi P, Stridsberg M, Magnoli M, Christensen G, Moise G, Urbano MC, Gattinoni L, Pesenti A, Latini R, Omland T; ALBIOS Biomarkers Study Investigators.

Crit Care Med. 2018 May;46(5):e404-e410. doi: 10.1097/CCM.0000000000003050.

PMID:
29481425
40.

The predictive value of NT-proBNP and hs-TnT for risk of death in cardiac surgical patients.

Brynildsen J, Petäjä L, Pettilä V, Nygård S, Vaara ST, Linko R, Okkonen M, Hagve TA, Soininen L, Suojaranta-Ylinen R, Lyngbakken MN, Omland T, Røsjø H.

Clin Biochem. 2018 Mar;53:65-71. doi: 10.1016/j.clinbiochem.2018.01.012. Epub 2018 Jan 31.

PMID:
29371002
41.

The cardiac troponin response following physical exercise in relation to biomarker criteria for acute myocardial infarction; the North Sea Race Endurance Exercise Study (NEEDED) 2013.

Skadberg Ø, Kleiven Ø, Ørn S, Bjørkavoll-Bergseth MF, Melberg TH, Omland T, Aakre KM.

Clin Chim Acta. 2018 Apr;479:155-159. doi: 10.1016/j.cca.2018.01.033. Epub 2018 Feb 2.

PMID:
29366834
42.

Cardiac Troponin T Increase in Patients with Acute Ischemic Stroke with and without Cancer.

Faiz KW, Einvik G, Brekke PH, Omland T.

Clin Chem. 2018 Feb;64(2):404-406. doi: 10.1373/clinchem.2017.280016. Epub 2017 Nov 22. No abstract available.

PMID:
29167194
43.

Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study.

Gulati G, Heck SL, Røsjø H, Ree AH, Hoffmann P, Hagve TA, Norseth J, Gravdehaug B, Steine K, Geisler J, Omland T.

J Am Heart Assoc. 2017 Nov 8;6(11). pii: e006513. doi: 10.1161/JAHA.117.006513.

44.

Effect of candesartan and metoprolol on myocardial tissue composition during anthracycline treatment: the PRADA trial.

Heck SL, Gulati G, Hoffmann P, von Knobelsdorff-Brenkenhoff F, Storås TH, Ree AH, Gravdehaug B, Røsjø H, Steine K, Geisler J, Schulz-Menger J, Omland T.

Eur Heart J Cardiovasc Imaging. 2018 May 1;19(5):544-552. doi: 10.1093/ehjci/jex159.

PMID:
29106497
45.

Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 study.

Winther JA, Brynildsen J, Høiseth AD, Strand H, Følling I, Christensen G, Nygård S, Røsjø H, Omland T.

Respir Res. 2017 Nov 3;18(1):184. doi: 10.1186/s12931-017-0665-z.

46.

Fibroblast growth factor 23 in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study.

Lyngbakken MN, Pervez MO, Brynildsen J, Pedersen MH, Sølvernes J, Christensen G, Høiseth AD, Omland T, Røsjø H.

Clin Biochem. 2018 Feb;52:41-47. doi: 10.1016/j.clinbiochem.2017.10.015. Epub 2017 Oct 24.

PMID:
29074091
47.

Early diagnosis of acute coronary syndrome.

Katus H, Ziegler A, Ekinci O, Giannitsis E, Stough WG, Achenbach S, Blankenberg S, Brueckmann M, Collinson P, Comaniciu D, Crea F, Dinh W, Ducrocq G, Flachskampf FA, Fox KAA, Friedrich MG, Hebert KA, Himmelmann A, Hlatky M, Lautsch D, Lindahl B, Lindholm D, Mills NL, Minotti G, Möckel M, Omland T, Semjonow V.

Eur Heart J. 2017 Nov 1;38(41):3049-3055. doi: 10.1093/eurheartj/ehx492.

PMID:
29029109
48.

Sedentary Behavior and Subclinical Cardiac Injury: Results From the Dallas Heart Study.

Harrington JL, Ayers C, Berry JD, Omland T, Pandey A, Seliger SL, Ballantyne CM, Kulinski J, deFilippi CR, de Lemos JA.

Circulation. 2017 Oct 10;136(15):1451-1453. doi: 10.1161/CIRCULATIONAHA.117.029493. No abstract available.

49.

Glycosylated Chromogranin A: Potential Role in the Pathogenesis of Heart Failure.

Ottesen AH, Christensen G, Omland T, Røsjø H.

Curr Heart Fail Rep. 2017 Dec;14(6):478-488. doi: 10.1007/s11897-017-0360-x. Review.

PMID:
28975588
50.

Biomarker-Based Risk Models to Risk Stratify Patients With Stable Coronary Heart Disease.

Omland T, Kullo IJ.

J Am Coll Cardiol. 2017 Aug 15;70(7):827-829. doi: 10.1016/j.jacc.2017.06.051. No abstract available.

Supplemental Content

Loading ...
Support Center